JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christakis, G. T.
Right arrow Articles by Baird, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christakis, G. T.
Right arrow Articles by Baird, R. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 91, 647-661, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Diltiazem cardioplegia. A balance of risk and benefit

GT Christakis, SE Fremes, RD Weisel, JG Tittley, DA Mickle, J Ivanov, MM Madonik, AM Benak, PR McLaughlin and RJ Baird

Calcium channel blockers may prevent myocardial injury during cardioplegia and reperfusion. A prospective, randomized trial was instituted to evaluate the hemodynamic and myocardial metabolic recovery in 40 patients undergoing elective aorta-coronary bypass with either diltiazem in crystalloid potassium cardioplegia (n = 20) or crystalloid potassium cardioplegia (n = 20). In a preliminary trial, doses between 150 and 250 micrograms/kg reduced the period of heart block after cross-clamp removal (90 +/- 110 minutes) from that found with higher doses and improved myocardial metabolism. In the randomized trial, diltiazem cardioplegia (150 micrograms/kg) produced coronary vasodilatation during cardioplegia and produced less reactive hyperemia during reperfusion. Myocardial oxygen extraction was lower and myocardial lactate production was less after diltiazem cardioplegia during reperfusion. Tissue adenosine triphosphate and creatine phosphate concentrations were preserved better after diltiazem cardioplegia. The postoperative creatine kinase MB levels were less (p less than 0.05) after diltiazem cardioplegia, which indicated less myocardial injury. Postoperative volume loading demonstrated that systolic function (the relation between systolic blood pressure and end- systolic volume index) was depressed after diltiazem cardioplegia compared to crystalloid cardioplegia, but cardiac index was higher because afterload (mean arterial pressure) was lower and preload (end- diastolic volume index) was higher. Diltiazem cardioplegia preserved high-energy phosphates, improved postoperative myocardial metabolism, and reduced ischemic injury after elective coronary bypass. However, diltiazem was a potent negative inotrope and produced prolonged periods of electromechanical arrest. Diltiazem cardioplegia may be of value in patients with severe ischemia but should be used with caution in patients with ventricular dysfunction, and a dose-response relation must be established at each institution before clinical use.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski
Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Dagenais, R. Cartier, C. Hollmann, and J. Buluran
Calcium-Channel Blockers Preserve Coronary Endothelial Reactivity After Ischemia-Reperfusion
Ann. Thorac. Surg., April 1, 1997; 63(4): 1050 - 1056.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. Acikel, E. Hazan, N. Sariosmanoglu, H. Catalyurek, E. Silistreli, G. Guner, N. Saydam, Y. Tuncok, H. Guven, O. Karabay, et al.
Nisoldipine Cardioplegia in the Isolated Rabbit Heart
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 285 - 290.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning
Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The American Association for Thoracic Surgery.